Market Cap
68986000.00
Annovis Bio, Inc.
Exchange: nyse
ANVS is the ticker symbol for Anavex Life Sciences Corp., a biopharmaceutical company listed on the New York Stock Exchange (NYSE). The company focuses on developing novel therapeutics for the treatment of neurodegenerative diseases and other central nervous system disorders. With a pipeline that includes potential treatments for Alzheimer's disease, Parkinson's disease, and other conditions, Anavex aims to address significant unmet medical needs through its innovative drug development programs.